2022, Number 4
Prognostic factors of thrombolytic failure in patients diagnosed with acute myocardial infarction
Language: Spanish
References: 15
Page: 853-865
PDF size: 344.17 Kb.
ABSTRACT
Introduction: the most important therapeutic measure in patients with ST-segment elevation acute myocardial infarction is reperfusion of the ischemic territory; fibrinolysis is the primary strategy in many hospitals. Early diagnosis of those patients with risk of failed thrombolysis is vital.Objective: to identify prognostic factors of thrombolytic failure in patients diagnosed with ST- segment elevation acute myocardial infarction.
Methods: a descriptive and prospective study including patients treated in the Emergency department at "Joaquín Albarrán" Clinical and Surgical Hospital, who were diagnosed with the previously mentioned disease and treated with recombinant streptokinase, between November 2018 and May 2020. A number of 66 patients were included in the investigation. Age, gender, arterial hypertension, diabetes mellitus, time between onset of symptoms and onset of fibrinolysis, location of the infarction, QRS complex duration, duration and depth of the wave were the analyzed variables.
Results: thrombolysis failed in 27 patients (40.9%). Time of performing thrombolysis, duration and depth of the Q wave, as well as the QRS duration showed values with significant differences between both groups (p<0.05). The multivariate analysis confirmed the duration and depth of the Q wave as independent factors, predictors of thrombolysis failure: (OR= 14.50; 95% CI 1.58-132.33); (OR: 1.69; 95% CI 1.27-2.26), respectively.
Conclusions: the analysis of the depth and duration of the Q wave in the initial electrocardiogram of the studied patients allows us to predict a subpopulation of patients with risk of failed thrombolysis.
REFERENCES
Ibáñez B, James S, Agewal S, Antunes M, Bucciarelli-Ducci Ch, Bueno H, et al. ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J [internet]. 2018 [citado 3 ene. 2021];39(2):[aprox. 20 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28886621/1.
Bawaskar H, Bawaskar P, Bawaskar P. Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital. J Family Med Prim Care [internet]. 2019 [citado 3 ene. 2021];8(1):[aprox. 9 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30911482/2.
Hamid Sh, Kundal V, Mahajan N, Singh P. Failure of Thrombolysis with Streptokinase In Acute Myocardial Infarction Using ECG Criteria: An Observational Study. JK Science [internet]. 2015 [citado 3 ene. 2021];17(3):[aprox. 6 p.]. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/sea-1793645.
Pourmousavia M, Tajlil A, Darabad B, Pourmousavia L. The impact of diabetes on electrocardiographic ST resolution and clinical outcome of acute ST elevation myocardial infarction following fibrinolytic therapy. Cor et Vasa [internet]. 2016 [citado 3 ene. 2021];58(6):[aprox. 6 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S00108650150011379.
Kacmaz F, Maden O, Celebi S, Ureyen C, Alyan Ö, Erbay A, et al. Relationship of Admission QRS Duration and Changes in QRS Duration With Myocardial Reperfusion in Patients With Acute ST Segment Elevation Myocardial Infarction (STEMI) Treated With Fibrinolytic Therapy. Circ J [internet]. 2008 [citado 3 ene. 2021];72:[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18503209/10.
Tsukahara K, Kimura K, Kosuge M, Shimizu T, Sugano T, Hibi K, et al. Clinical implications of intermediate QRS prolongation in the absence of bundle-branch block in patients with ST-segment-elevation acute myocardial infarction. Circ J [internet]. 2005 [citado 3 ene. 2021];69:[aprox. 5 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15635198/11.
Armstrong P, Fu Y, Westerhout C, Hudson M, Mahaffey K. Baseline Q-Wave Surpasses Time from Symptom Onset as a Prognostic Marker in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention. J American College Cardiol [internet]. 2009 [citado 3 ene. 2021];53(17):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19389560/13.
Waks J, Sabatine M, Cannon Ch, Morrow D, Gibson M, Wiviott S. Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial. Clin Cardiol [internet]. 2014 [citado 3 ene. 2021];37(3):[aprox. 6 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24452727/14.
Mostafavi-Toroghi H, Naghib E, Hosseini G, Mouhebati M, Heidari A. Factors Indicating the Best Reperfusion Methods In Acute Myocardial Infarction: Q wave better than Time of Onset. Kuwait Medical J [internet]. 2014 [citado 3 ene. 2021];46(3):[aprox. 4 p.]. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/emr-14731915.